ClinVar Miner

Submissions for variant NM_001040142.2(SCN2A):c.4223T>C (p.Val1408Ala)

dbSNP: rs1574716488
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000805576 SCV000945536 likely pathogenic Seizures, benign familial infantile, 3; Developmental and epileptic encephalopathy, 11 2019-01-14 criteria provided, single submitter clinical testing This sequence change replaces valine with alanine at codon 1408 of the SCN2A protein (p.Val1408Ala). The valine residue is highly conserved and there is a small physicochemical difference between valine and alanine. This variant is not present in population databases (ExAC no frequency). This variant has been observed to be de novo in an individual affected with neonatal seizures (Invitae). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego RCV000853351 SCV000996216 likely pathogenic Developmental and epileptic encephalopathy, 11 2018-11-25 criteria provided, single submitter clinical testing This variant has not been previously reported or functionally characterized in the literature to our knowledge. It is absent from the ExAC and gnomAD population databases and thus is presumed to be rare. The variant is located in the functional domain of the protein (ion transport domain). The c.4223T>C (p.Val1408Ala) variant affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. Analysis of the parental samples was negative for the variant, indicating this variant likely occurred as a de novo event. Based on the current available evidence, the c.4223T>C (p.Val1408Ala) variant is classified as likely pathogenic.
GenomeConnect - Simons Searchlight RCV001265329 SCV001443446 likely pathogenic Complex neurodevelopmental disorder 2016-08-02 no assertion criteria provided provider interpretation Submission from Simons Searchlight facilitated by GenomeConnect. Variant interpreted by the Simons Searchlight team most recently on 2016-08-02 and interpreted as Likely Pathogenic. Variant was initially reported on 2014-03-04 by GTR ID of laboratory name Oslo University . The reporting laboratory might also submit to ClinVar.
Neurology Department, Shenzhen Children's Hospital RCV001849109 SCV002099459 pathogenic Early infantile epileptic encephalopathy with suppression bursts 2022-02-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.